BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10206195)

  • 1. Managing the climacteric.
    Rozenberg S; Vandromme J; Kroll M; Vasquez JB
    Int J Fertil Womens Med; 1999; 44(1):12-8. PubMed ID: 10206195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance to hormone replacement therapy.
    Rozenberg S; Vandromme J; Kroll M; Pastijn A; Liebens F
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():23-32. PubMed ID: 7581586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S
    Maturitas; 2006 Nov; 55(4):308-16. PubMed ID: 16730140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compliance with hormone replacement therapy].
    Rozenberg S; Vandromme J; Kroll M; Twagirayezu P; Vyankandondera J
    Rev Med Brux; 1995; 16(4):295-8. PubMed ID: 7481246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
    Bakken K; Eggen AE; Lund E
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing menopause: a critical feminist engagement.
    Guillemin MN
    Scand J Public Health; 1999 Dec; 27(4):273-8. PubMed ID: 10724470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone replacement therapy--women's expectations and fears].
    Schultz-Zehden B
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):180-8. PubMed ID: 10802891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the risk-benefit ratio of hormonal replacement therapy for menopause and susceptible elements in maximizing compliance].
    Lopes P; Mensier A
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):694-8. PubMed ID: 8991903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Climacteric: concept, consequence and care.
    Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom KK
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S1-15. PubMed ID: 12188398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
    Trinh XB; Peeters F; Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):250-3. PubMed ID: 16144734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
    Ushiroyama T; Ikeda A; Sakuma K; Ueki M
    J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estrogen therapy in climacteric. Current views in an evidence-based perspective].
    Nilsson K
    Lakartidningen; 2001 Jul; 98(28-29):3225-8. PubMed ID: 11496812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
    Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
    Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in breast cancer survivors.
    Xydakis AM; Sakkas EG; Mastorakos G
    Ann N Y Acad Sci; 2006 Dec; 1092():349-60. PubMed ID: 17308160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.